Novavax, Inc.

Novavax, Inc.verified

NVAX

Price:

$8.47

Market Cap:

$1.36B

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical...[Read more]

Industry

Biotechnology

IPO Date

1995-12-05

Stock Exchange

NASDAQ

Ticker

NVAX

The ROE as of November 2024 (TTM) for Novavax, Inc. (NVAX) is 44.82%

According to Novavax, Inc.’s latest financial reports and current stock price. The company's current ROE is 44.82%. This represents a change of 556.07% compared to the average of 6.83% of the last 4 quarters.

Novavax, Inc. (NVAX) Historical ROE (quarterly & annually)

How has NVAX ROE performed in the past?

The mean historical ROE of Novavax, Inc. over the last ten years is 592.64%. The current 44.82% ROE has changed -92.44% with respect to the historical average. Over the past ten years (40 quarters), NVAX's ROE was at its highest in in the December 2016 quarter at 1.03%. The ROE was at its lowest in in the September 2020 quarter at -185.37%.

Quarterly (TTM)
Annual

Average

592.64%

Median

89.90%

Minimum

-68.16%

Maximum

5.05%

Novavax, Inc. (NVAX) ROE by Quarter and Year

Discovering the peaks and valleys of Novavax, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 48.44%

Maximum Annual ROE = 5.05%

Minimum Annual Increase = -9514.06%

Minimum Annual ROE = -68.16%

Quarterly (TTM)
Annual
YearROEChange
202376.03%-26.73%
2022103.76%-79.07%
2021495.84%-827.47%
2020-68.16%-197.45%
201969.94%-36.42%
2018110.01%-39.10%
2017180.64%-96.42%
20165.05%-9514.06%
2015-53.62%48.44%
2014-36.12%41.23%

Novavax, Inc. (NVAX) Average ROE

How has NVAX ROE performed in the past?

The current ROE of Novavax, Inc. (NVAX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

225.21%

5-year avg

135.48%

10-year avg

592.64%

Novavax, Inc. (NVAX) ROE vs. Peers

How is NVAX’s ROE compared to its peers?

Novavax, Inc.’s ROE is greater than Moderna, Inc. (-17.68%), greater than Inovio Pharmaceuticals, Inc. (-26438.24%), greater than BioNTech SE (-2.38%), greater than Vaxart, Inc. (-110.46%), less than AstraZeneca PLC (16.57%),

CompanyROEMarket cap
-17.68%$15.82B
-26438.24%$106.23M
-2.38%$27.12B
-110.46%$136.49M
16.57%$203.49B

Build a custom stock screener for Novavax, Inc. (NVAX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novavax, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Novavax, Inc. (NVAX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Novavax, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Novavax, Inc.'s ROE?

How is the ROE calculated for Novavax, Inc. (NVAX)?

What is the highest ROE for Novavax, Inc. (NVAX)?

What is the 3-year average ROE for Novavax, Inc. (NVAX)?

What is the 5-year average ROE for Novavax, Inc. (NVAX)?

How does the current ROE for Novavax, Inc. (NVAX) compare to its historical average?